Hereditary hemochromatosis (HH) type I is a disorder of iron metabolism caused by a mutation in the HFE gene. While the prevalence of the mutation is very high, its penetrance seems very low. The goal of our study was to determine whether hepcidin, a recently identified iron-regulatory peptide, could be a genetic modifier contributing to the HH phenotype. In mice, deficiency of either HFE (Hfe-/-) or hepcidin (Usf2-/-) is associated with the same pattern of iron overload observed in patients with HH. We intercrossed Hfe-/-and Usf2+/-mice and asked whether hepcidin deficiency increased the iron burden in Hfe-/-mice.
INTRODUCTION
Hereditary hemochromatosis (HH) is a genetic disorder of iron metabolism resulting in a chronic increase in intestinal iron absorption. As the disease progresses, patients develop toxic iron overload and complications of tissue damage including liver cirrhosis, hepatocarcinoma, and heart disease. Most patients with HH are homozygous for a missense mutation (C282Y) that disrupts the conformation of HFE, an atypical major histocompatibility class I molecule 1 .
Similar to human patients, mice lacking the Hfe protein [2] [3] [4] or producing a mutated protein analogous to the human C282Y protein 3 develop increased hepatic iron levels and elevated transferrin saturation. While HH is among the most prevalent genetic disorders (about five people in 1000 are homozygotes for the C282Y mutation), the clinical penetrance of the mutation is low, suggesting that the HFE C282Y mutation is a necessary but not sufficient [15] [16] [17] . These data support the hypothesis that inappropriate hepcidin regulation contributes to the iron loading phenotype. In the present study, we asked whether haploinsufficiency for hepcidin would exacerbate the phenotype of Hfe-/-mice.
MATERIALS AND METHODS

Animals
Hfe-/-mice and hepcidin-deficient Usf2-/-mice were described previously 3, 12 . It is noteworthy that the Usf2-/-mice (originally mixed 129/Sv-C57BL/6) were bred to uniformity genotype analysis was performed as previously described 12 . Hfe-/-and Usf2+/-mice were interbred and resulting double heterozygous progeny were crossed with Hfe-/-Usf2+/+ mice.
Due to the poor viability of Usf2 -/-mice 12 , Hfe-/-Usf2-/-animals could not be investigated.
Liver iron determination
Liver non-heme iron content was determined as described previously 18 .
RNA isolation and PCR analysis
Total RNA was isolated and double-stranded cDNA was synthesized as described 
Statistical analysis
Results are expressed as mean ± SD for n animals, and statistical analysis was performed using Student's t-test (unpaired, two tailed). All statistical analyses were performed using StatView version 5.0 (SAS Institute Inc.). To study the effects of Hfe and Usf2 genotypes on hepatic iron content and hepc1 gene expression, a Kruskal-Wallis test was performed.
RESULTS AND DISCUSSION
We intercrossed Hfe-/-mice and Usf2+/-mice to further investigate the role of hepcidin in the pathogenesis of liver iron overload in HH. Usf2+/-mice carry only one functional allele for both hepc1 and hepc2, the gene products resulting from a tandem duplication of the hepcidin gene in mice, due to insertional disruption of one allele of Usf2, a gene that lies in close proximity to the murine hepcidin locus. Although the roles of these proteins are incompletely We hypothesized that the physiological effects of decreased hepcidin synthesis might become more pronounced with increasing age, as a cumulative effect on intestinal iron absorption. To further investigate this possibility, we analyzed a second group of mice at 8 weeks of age. In contrast to 4 week old animals, we observed a sexual dimorphism in iron loading, as previously reported 20 , with females accumulating more iron than males (data not shown). At 8 weeks we found that haploinsufficiency for hepcidin was associated with increased liver iron overload (Fig.2B) . It is worth noting that at 8 weeks, the amount of hepc1 remained low in the Hfe-/-Usf2+/-mice as compared to the other groups ( Fig.2A) . This difference however did not reach statistical significance most likely due to the wide range in hepc1 expression in the Hfe-/-Usf2+/+ group.
In conclusion, our result confirms the key role of hepcidin in the control of iron homeostasis and further highlight that decreased hepcidin contributes to the iron homeostasis abnormalities characteristic of HH. Although the mechanism of action of hepcidin has not yet been established, we speculate that hepcidin or its analogs may prove to be useful in the treatment of hemochromatosis. 
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